Formulation Variations

As with all treatment programs, the key to achieving maximum benefit is compliance. Antiperspirant products can require up to 10 consecutive days to reach maximum efficacy and benefits can be completely eliminated within 14 days of treatment termination. Barriers to compliance are typically associated with products’ aesthetics rather than skin irritation. Refer to Table 3 for details on formulation and compliance. Erythema and

Table 3 Formulation and Compliance

Product types

Active types

Carrier system

Barriers to compliance

Comments

Water-based

Aluminum chloride

Water

Skin irritation

Only form avail-

roll-on

Aluminum

Oil in water

(aluminum

able with alumi-

chlorohydrate Aluminum zirconium tetrachlorohy- drate gly

Emulsion

chloride) Wet sticky skin feel

num chloride in mass market

Powder-based

Aluminum zirco-

Anhydrous

Wet skin feel at

roll-on

nium tetrachlor – ohydrate gly

emollients

application

Gels

Aluminum zirco­nium tetrachlor – ohydrate gly

Water in silicone emollient emulsion

Sticky skin feel

Stick

Aluminum chloro-

Silicone emolli-

White residue

Most common

hydrate

ent system

on skin and

product form in

Aluminum zir­conium trichlor – ohydrate gly Aluminum zirconium tetrachlorohy – drate gly

solidified with wax

clothes

mass market

Creams

Aluminum zirco-

Silicone emolli-

Skin feel at

Generally the most

nium trichloro – hydrate gly Aluminum zirconium tetrachlorohy- drate gly

ent system thickened with wax

application

efficacious form in mass market

stinging can still be common for products containing Aluminum Chloride and/or high levels of glycol or fragrance but are not common on most commercial antiperspirants. Unscented products based on the emollients cyclopentasiloxane and dimethicone have very good skin compatibility.

Most common barriers to compliance are associated with the skin feel of product, product appearance on skin, product transfer to clothes, and fragrance. Typically, consumers view antiperspirant application as part of their total grooming process and often create application behaviors that reduce product efficacy. Behaviors such as removing the product shortly after application, not applying the dose of product recommended by the manufacturer, or only applying it to a portion of the axilla will reduce efficacy. Encouraging consumers to identify a product form that allows them to comply with a daily application routine will maximize their observed benefit. Efficacy can further be improved by placing the user on a nighttime application to remove issues with the user’s morning grooming routine. Night time application allows the active to enter the duct during a time of low sweating rates and allows for more efficient plug formation.

Updated: June 23, 2015 — 3:54 am